AI Agent Studio

Zusammenfassung

Oracle Corporation is a global enterprise software and cloud services provider with a large installed base in databases, middleware, and ERP/HCM applications, increasingly monetized through subscription cloud delivery (Oracle Cloud Infrastructure/OCI and Oracle Cloud Applications). The company’s core competencies remain mission‑critical database technology, integrated enterprise application suites, and vertically oriented solutions (including healthcare via Cerner), with a strategic emphasis on scaling OCI for AI training/inference workloads and large contracted capacity deals. Market position is differentiated by (1) deep enterprise relationships and high switching costs in database/application estates, (2) an integrated stack (database + apps + infrastructure) that can simplify procurement and operations for regulated customers, and (3) rapidly expanding OCI capacity tied to multi‑year contracts. Recent disclosures highlight exceptionally large contracted demand: Oracle reported remaining performance obligations (RPO) of $638B, materially above many expectations, positioning backlog as a key near‑term narrative driver. (investing.com) However, the investment debate has shifted toward the financing and cash flow implications of the AI infrastructure buildout. In the most recent earnings cycle (Q4 and FY2026 results released June 10, 2026), Oracle reported record results and reiterated FY2027 total revenue guidance of $90B while raising FY2027 non‑GAAP EPS guidance to $8.05 (management framing this as ~18% growth after adjusting for one‑time items). (investor.oracle.com) Reuters coverage emphasized capex and funding: Oracle indicated fiscal 2027 capex plans above Street expectations and referenced raising nearly $40B via debt/equity financing in 2027, reflecting the scale of AI datacenter investment. (investing.com) Credit risk has become more salient: S&P Global Ratings commentary and related reporting point to stretched credit metrics and the sensitivity of free cash flow to the pace of infrastructure spending and lease-like commitments. (spglobal.com) On valuation, recent market data sources show Oracle trading at roughly mid‑teens to high‑teens forward P/E (depending on estimate set/date) and mid‑20s trailing P/E, implying the market is discounting both strong earnings growth and elevated balance‑sheet/cash‑flow risk. (stockanalysis.com) With current price requested “in EUR,” a practical reference is Oracle’s NYSE quote of $126.41 (as of July 17, 2026 close per Oracle IR) and the ECB EUR/USD reference rate around 1.1389 USD per EUR (July 27, 2026), implying ~€111 per share on a simple spot conversion (illustrative, not a live quote). (investor.oracle.com) Outlook (short‑ to medium‑term) is primarily governed by (a) OCI capacity delivery and conversion of RPO into recognized revenue, (b) operating leverage versus depreciation/hosting costs, and (c) financing conditions (debt/equity issuance, credit rating trajectory). The near‑term setup is attractive if backlog converts on schedule and margins hold, but risk‑adjusted returns depend on whether capex intensity and funding needs stabilize before credit metrics deteriorate further.

Key Takeaways

1. Oracle’s growth narrative is increasingly OCI/AI-led, supported by very large contracted backlog (RPO reported at $638B), which is central to the revenue visibility argument. (investing.com)
2. FY2027 guidance is a key anchor: management confirmed $90B total revenue guidance and raised non‑GAAP EPS guidance to $8.05. (investor.oracle.com)
3. Capex and funding are the main investor constraint: Reuters reported Oracle expects to raise nearly $40B via debt/equity in 2027 and flagged capex above expectations. (investing.com)
4. Credit and cash-flow scrutiny is rising: S&P analysis indicates Oracle’s credit metrics may remain stretched for multiple years given AI infrastructure commitments and debt-like financing structures. (spglobal.com)
5. Valuation appears less demanding than many large-cap software peers on forward earnings (mid‑teens to high‑teens forward P/E in recent datasets), but that discount reflects financing/cash-flow risk rather than a pure growth skepticism. (stockanalysis.com)

Action-Ideen

Contrarian Insights

• • Contrarian (more constructive): The market may be over-penalizing Oracle for capex while underweighting the earnings guideposts already provided (FY2027 revenue $90B; non‑GAAP EPS $8.05) and the scale of contracted demand (RPO $638B). If OCI buildout is substantially pre-sold, the capex profile can be interpreted as capacity investment with clearer monetization than typical speculative expansion. (investor.oracle.com)
• • Contrarian (more cautious): Even with record RPO, the equity risk may be less about demand and more about the durability of free cash flow after accounting for debt-like financing structures and lease commitments. S&P’s framing that adjusted leverage could remain stretched for multiple years suggests that headline earnings growth may not translate into balance-sheet improvement on the timeline equity holders expect. (spglobal.com)